/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

S

Sandra A. Mitchell

National Institutes of Health(US)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

376

Papers

19.9K

Citations

60

h-index

164

i10-index

Sandra A. Mitchell is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Cancer survivorship and care & Childhood Cancer Survivors' Quality of Life & Hematopoietic Stem Cell Transplantation. The author has an h-index of 60, co-authored 320 publications.

ORCID: 0000-0002-4153-9972

Research Topics

Cancer survivorship and care Childhood Cancer Survivors' Quality of Life Hematopoietic Stem Cell Transplantation Palliative Care and End-of-Life Issues Health Systems, Economic Evaluations, Quality of Life

Papers by this author

works

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report

2014 · Biology of Blood and Marrow Transplantation · 5,286 citations

https://doi.org/10.1016/j.bbmt.2014.12.001

Madan Jagasia Hildegard Greinix Mukta Arora Kirsten M. Williams

Validity and Reliability of the US National Cancer Institute’s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

2015 · JAMA Oncology · 979 citations

https://doi.org/10.1001/jamaoncol.2015.2639

Amylou C. Dueck Tito R. Mendoza Sandra A. Mitchell Bryce B. Reeve

International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: recommendations of the SISAQOL Consortium

2020 · The Lancet Oncology · 290 citations

https://doi.org/10.1016/s1470-2045(19)30790-9

Corneel Coens Madeline Pe Amylou C. Dueck Jeff A. Sloan

Analysing data from patient-reported outcome and quality of life endpoints for cancer clinical trials: a start in setting international standards

2016 · The Lancet Oncology · 187 citations

https://doi.org/10.1016/s1470-2045(16)30510-1

Andrew Bottomley Madeline Pe Jeff A. Sloan Ethan Basch

Clinical Activity of the γ-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors (Aggressive Fibromatosis)

2017 · Journal of Clinical Oncology · 187 citations

https://doi.org/10.1200/jco.2016.71.1994

Shivaani Kummar Geraldine O’Sullivan Coyne T. Khanh Barış Türkbey

Linguistic validation of the simplified Chinese version of the US National Cancer Institute’s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE™)

2020 · BMC Cancer · 167 citations

https://doi.org/10.1186/s12885-020-07631-5

Karis Kin Fong Cheng Sandra A. Mitchell Natalie Chan Emily Zhao-Feng Ang

Research topics

topics

Cancer survivorship and care

Childhood Cancer Survivors' Quality of Life

Hematopoietic Stem Cell Transplantation

Palliative Care and End-of-Life Issues

Health Systems, Economic Evaluations, Quality of Life

Chat about Author

Papers

Chat

Click to start Chat